Transcranial Electrical Stimulation in Treatment of Depression: A Systematic Review and Meta-Analysis
PMCID: PMC12177679
PMID: 40531534
DOI: 10.1001/jamanetworkopen.2025.16459
Journal: JAMA network open
Publication Date: 2025-6-18
Authors: Ren C, Pagali SR, Wang Z, Kung S, Boyapati RB, et al.
Key Points
- tDCS combined with medication showed significant improvement in depression with comorbid conditions
- tACS demonstrated improved depressive symptoms in MDD, with response rates varying by stimulation parameters
- Electrode placement and stimulation intensity are critical factors in treatment efficacy, warranting individualized approach
Summary
This comprehensive systematic review and meta-analysis examined the efficacy of transcranial electrical stimulation (tES) techniques in treating major depressive disorder (MDD) and depression with comorbid psychiatric and medical conditions. Analyzing 88 randomized clinical trials involving 5,522 participants, the study revealed nuanced findings about different tES modalities, with transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) showing promising therapeutic potential.
The research demonstrated that tDCS combined with medication produced larger effect sizes in depression with medical and psychiatric comorbidities, with more modest benefits in MDD. Notably, tACS was associated with improved depressive symptoms and response rates in MDD patients. The meta-analysis also highlighted the overall tolerability of tES interventions, with predominantly mild to moderate adverse events, suggesting potential as an adjunctive or alternative treatment strategy for depression.